BASIC CONCEPT & TYPES OF LYMPHOMA || BY KAUSHIK SIR

Main ideas / lessons conveyed

1) Lymphoma vs. leukemia (core distinction)

Leukemia

• Type: A neoplastic (cancerous) condition arising from hematopoietic / stem-cell lineage.
• What happens: Leads to uncontrolled proliferation of immature cells in the bone marrow.
• Distribution: The bone marrow becomes overloaded, and cells spill into the bloodstream, making the disease appear diffusely throughout circulation.
• “Diffuse” concept: Blood taken from different sites yields similar abnormal findings.
• Analogy: Milk poured into a container → it spreads to fill the container (not localized).

Lymphoma

• Type: A tumor mass (discrete growth) primarily affecting the lymph nodes/lymphatic system.
• What happens: Presented as a discrete mass, not diffuse bloodstream spread.
• Analogy: Butter formed from milk → a solid, localized mass that doesn’t disperse throughout the container.
• Cell emphasis: A cancer involving primarily mature T or B cells (particularly mature lymphocytes), rather than stem/immature stages.

2) Cell maturity concept (important emphasis)

The speaker repeatedly stresses:

• Leukemia: involves immature cells / stem-cell stages.
• Lymphoma: involves mature T or B cells, not immature/stem cells.

---

Types of lymphoma described

A) Hodgkin lymphoma (HK / “Hoskin” in subtitles)

Frequency

• Only about 10% of lymphomas (as stated).

Cell type involvement

• Predominantly B-cell related lymphoma.

Age distribution (bimodal)

• Young adults: 15–35 years
• Older adults: >55 years

Spread pattern

• Spreads in an orderly fashion and is described as restricted to lymph nodes in the speaker’s framing.

Severity / prognosis

• Less severe, with better prognosis, more curable, and treated with more localized methods.

Key histopathology feature

• Presence of Reed–Sternberg (RS) cells (mislabeled in subtitles as “rebanb cell” / “re turnbuck cell”).
• RS cells are described as:
  • Large/blobby nucleus (owl-like appearance)
  • Marker expression mentioned as CD15 and CD30

Etiology (cause)

• Epstein–Barr virus (EBV) is highlighted as a specific important cause.
• Proposed mechanism (as described):
  • EBV interacts with B cells, driving activation of proteins that contribute to Hodgkin lymphoma.

---

B) Non-Hodgkin lymphoma (NHL / “non-hostkin” in subtitles)

Frequency

• About 90% of lymphomas (as stated).

Cell type involvement

• Involves both B and T cells (subtitles suggest B is most common).
• The speaker emphasizes mature T/B cells are involved (not immature stages).

Spread pattern

• Can spread beyond lymph nodes to:
  • Bone marrow
  • GI tract (gut/stomach/small intestine)
  • Liver
  • Spine (mentioned)
• More broadly described as involving other organs rather than staying localized.

Etiology / genetics emphasis

• Translocation and gene fusion are presented as key.
• Specific translocation described:
  • Between chromosome 8 and chromosome 14
• Gene fusion (conceptually):
  • Chromosome 8: contains a growth/proliferation-related gene (“c-myc” in concept)
  • Chromosome 14: has the immunoglobulin heavy chain (IgH) gene
  • Fusion → uncontrolled proliferation

Prognosis / treatment approach

• More common in older adults (>60 years) (as stated).
• Worse prognosis, less curable, and treated with more generalized methods.

Key histopathology feature

• “Starry sky appearance”
  • Blue lymphoma cells form the “sky”
  • Pale/white patches correspond to tingible macrophages
  • Together they create the “star” pattern

Major distinguishing point from Hodgkin

• RS/Reed–Sternberg cells are absent in Non-Hodgkin lymphoma (as stated).

---

Mechanisms (immunology-based explanation) described

1) Normal humoral immunity process (simplified)

A step-by-step chain leading to antibody production:

1. Pathogen enters the body
2. Macrophage engulfs the pathogen
   • Pathogen contents are degraded inside the macrophage.
3. Antigen is presented via MHC-II on the macrophage surface
4. Macrophage migrates to a lymph node
5. T cell recognizes presented antigen (via the T cell receptor)
   • T cell becomes activated
6. Activated T cell activates B cell
7. B cell activation → proliferation
8. B cells undergo selection:
   • Many B cell clones are produced
   • Each clone tests affinity for the antigen
   • Clones with highest affinity survive
   • Lower-affinity clones undergo apoptosis (programmed cell death)

2) How lymphoma arises from the described mechanism

Hodgkin lymphoma (as described)

• Mutation occurs in activated/proliferating B cells.
• Problem introduced: apoptosis that should eliminate low-affinity clones fails.
• Result: multiple clones survive, causing excessive proliferation and mass formation.
• These malignant/proliferating B cells are said to develop Reed–Sternberg cells.

Non-Hodgkin lymphoma (as described)

• Mutation + translocation-driven gene fusion causes uncontrolled proliferation in mature T/B cells.
• Result: lymphoma growth and possible spread beyond lymph nodes.

---

Speaker / sources featured

• Speaker: “Kaushik Sir” (referred to in the video title and spoken throughout)
• External sources/organizations named: None, aside from general biomedical terms and Epstein–Barr virus (EBV) as a cause.